Company Filing History:
Years Active: 2016-2020
Title: Indrajit Ghosh: Innovator in Pharmaceutical Compositions
Introduction
Indrajit Ghosh is a notable inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work primarily focuses on innovative formulations that address various medical disorders.
Latest Patents
Ghosh's latest patents include formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide. These patents provide pharmaceutical compositions and dosage forms of this compound, or its pharmaceutically acceptable stereoisomers, tautomers, solid forms, polymorphs, salts, hydrates, clathrates, or solvates. The patents also detail methods for treating, managing, or preventing disorders that can be addressed by inhibiting the JNK pathway in mammals using these pharmaceutical compositions. Additionally, the patents include methods for preparing salts of the compound.
Career Highlights
Throughout his career, Indrajit Ghosh has worked with prominent companies in the pharmaceutical industry, including Signal Pharmaceuticals, Inc. and Celgene Corporation. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Some of Ghosh's notable coworkers include Daozhong Zou and Nathan Andrew Boersen. Their collaborative efforts have likely enhanced the research and development of the innovative formulations he has patented.
Conclusion
Indrajit Ghosh's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex biochemical pathways and the potential for new treatments.